Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis

Technology appraisal guidance
Reference number: TA276
Published: 27 March 2013

Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Comments on the ACD received from the public through the NICE website

Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Comments on the ACD Received from the Public through the NICE Website
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Additional public comment received via email (reference article not included)

This page was last updated: 23 January 2013